Tag Archives: INFI

Healthcare Stock Tumbles; PhotoMedex (PHMD) Lifts Outlook while Oncolytics Biotech (ONCY) Stock Hikes after Positive Results of Reolysin – PHMD, ONCY, PFE, ONCY, INFI

Posted on December 14, 2012 by Geoff Noir

Healthcare showed bearish mood on Tuesday’s trading session and sector plunged -0.78%. If we look at the top movers of the sector so Oncolytics Biotech, Inc (USA) (NASDAQ:ONCY) and Infinity Pharmaceuticals Inc (NASDAQ:INFI) were major percentage gainer while major active …

Posted in Healthcare, Latest Headlines | Tagged INFI, Infinity Pharmaceuticals, NASDAQ:INFI, NASDAQ:ONCY, NASDAQ:PHMD, NYSE:PFE, Oncolytics Biotech, ONCY, PFE, Pfizer, PHMD, PhotoMedex | Comments Off

Healthcare Stocks In focus; Gilead (GILD) Board Approve 2-for-1 Stock Split while Peregrine Pharmaceuticals (PPHM) Posts Narrower Loss inQ2 – GILD, PPHM, PFE, INFI, OREX, JNJ

Posted on December 11, 2012 by Thomas Vedder

Investors reacted positively to the healthcare stocks on Monday. Key movement were seen in Infinity Pharmaceuticals Inc (NASDAQ:INFI) and Orexigen Therapeutics, Inc (NASDAQ:OREX) on percentage gainers side while Johnson & Johnson (NYSE:JNJ) was prominent stock on most active side.

Gilead …

Posted in Healthcare, Latest Headlines | Tagged GILD, Gilead Sciences, INFI, Infinity Pharmaceuticals, JNJ, Johnson, NASDAQ:GILD, NASDAQ:INFI, NASDAQ:OREX, NASDAQ:PPHM, NYSE:JNJ, NYSE:PFE, OREX, Orexigen Therapeutics, Peregrine Pharmaceuticals, PFE, Pfizer, PPHM | Comments Off

Investors pull plug on Infinity Pharmaceuticals

Posted on January 27, 2012 by Geoff Noir

Infinity Pharmaceutical (NASDAQ:INFI) was one of the worst performing stocks on the Nasdaq on Friday after the company announced that its Phase 2 clinical trial for the saridegib drug, which is aimed at treating patients with advanced pancreatic cancer, failed.…

Posted in Healthcare, Latest Headlines | Tagged INFI, Infinity Pharmaceuticals, NASDAQ:INFI | Comments Off

Stock Market Quotes and Streaming Charts - QuoteDaddy.com Level 2 Stock Quotes from Quote Daddy on Vimeo.

blogs

Lorimer Wilson Analyst

Dian L. Chu "EconMatters"

Paul Ebeling Trading News

Warren Bevan Precious Metals

eStocksDaily.com ("ESD") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities customers should buy or sell for themselves. The employees or affiliates of ESD may hold positions in the stocks or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities. ESD, the authors, the publisher, and all affiliates of ESD assume no responsibility or liability for your trading and investment results. Factual statements on the ESD's website, or in its publications, are made as of the date stated and are subject to change without notice. For ESD full disclaimer and disclosure go to our disclaimer page.It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by ESD are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of ESD's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on ESD's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.

Tag Archives: INFI

Healthcare Stock Tumbles; PhotoMedex (PHMD) Lifts Outlook while Oncolytics Biotech (ONCY) Stock Hikes after Positive Results of Reolysin – PHMD, ONCY, PFE, ONCY, INFI

Healthcare Stocks In focus; Gilead (GILD) Board Approve 2-for-1 Stock Split while Peregrine Pharmaceuticals (PPHM) Posts Narrower Loss inQ2 – GILD, PPHM, PFE, INFI, OREX, JNJ

Investors pull plug on Infinity Pharmaceuticals

Follow us

Most Popular Posts

blogs